Programs and Initiatives

Building upon a legacy of innovation that began nearly 150 years ago at University Hospitals Cleveland Medical Center, a number of programs and initiatives are helping forge medicine’s future, translating cardiovascular advances at the earliest stages of their development into improved patient care.

  • 70 faculty, fellows and staff conducting cardiovascular research with committed federally funded research exceeding $30 million
  • One of the most comprehensive cardiovascular imaging programs in the nation with state-of-the-art nuclear medicine, MRI, CT, vascular, cardiac catheterization and electrophysiology laboratories, including the novel Stereotaxis, NOGA and robotic 3-D navigation systems
  • World’s premier program in optical coherence tomography (OCT), a novel vascular imaging technology that provides micron-scale images of the coronary arteries
  • One of the largest calcium score preventive and therapeutic programs in the nation
  • A nationally recognized adult, nonembryonic, stem cell research center and leader of the Ohio Cell-Based Therapy Consortium
  • One of 45 sites nationally exploring expanded indications for transcatheter aortic valve replacement (TAVR, i.e. low and intermediate risk)
  • The first multidisciplinary Immuno-Cardiovascular Center for Cellular Diagnosis dedicated to discovery of novel immunological and cellular mechanisms of heart and vascular diseases
  • Leading worldwide clinical investigations of CardioKinetix’s first-of-its-kind catheter-based Parachute™ Ventricular Partitioning Device, a percutaneous ventricular restoration (PVR) therapy technology for patients with ischemic heart failure
  • International programs to eradicate rheumatic heart disease in underdeveloped countries
  • International network of leading academic medical centers in Europe, Asia, Japan, Africa and South America dedicated to expanding the frontiers of new technologies and therapies

These and other UH Cleveland Medical Center advances are poised to benefit the lives of patients affected by heart and vascular diseases for generations to come.